Literature DB >> 21189221

Estrogen replacement therapy for the treatment of postmenopausal genitourinary tract dysfunction.

Ariana L Smith1, Alan J Wein.   

Abstract

Considerable debate exists over the use of estrogen replacement therapy in post-menopausal women. Valuable level 1 evidence has been obtained through randomized controlled clinical trials; even so, little consensus exists on its use. Several genitourinary complaints correlate temporally with estrogen depletion at the time of menopause; likewise, estrogen replacement has been felt to improve many of these conditions. We will review the indications and evidence for estrogen therapy in the treatment of genitourinary symptoms as well as the hallmark clinical trials that address urinary incontinence, overactive bladder symptoms, urinary tract infections, vaginal atrophy and dyspareunia.

Entities:  

Mesh:

Year:  2010        PMID: 21189221

Source DB:  PubMed          Journal:  Discov Med        ISSN: 1539-6509            Impact factor:   2.970


  4 in total

Review 1.  Does estrogen have any real effect on voiding dysfunction in women?

Authors:  Michelle E Koski; Christopher J Chermansky
Journal:  Curr Urol Rep       Date:  2011-10       Impact factor: 3.092

2.  Dietary phytoestrogen improves relaxant responses to 17-β-estradiol in aged but not ovariectomised rat bladders.

Authors:  Suzzanne J Owen; Helen M Massa; Roselyn B Rose'Meyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-06-22       Impact factor: 3.000

3.  Nongenomic modulation of the large conductance voltage- and Ca2+-activated K+ channels by estrogen: A novel regulatory mechanism in human detrusor smooth muscle.

Authors:  Kiril L Hristov; Shankar P Parajuli; Aaron Provence; Eric S Rovner; Georgi V Petkov
Journal:  Physiol Rep       Date:  2017-07-27

4.  Postmenopausal overactive bladder.

Authors:  Jacek Tomaszewski
Journal:  Prz Menopauzalny       Date:  2014-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.